The appropriate use of proton-pump inhibitor co-therapy with non-steroidal anti-inflammatory drugs and cyclo-oxygenase-2 selective inhibitors.
Lanas
A
A
University of Zaragoza, Zaragosa, Spain.
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D001241:Aspirin / Q000627:therapeutic use; D000075202:Contraindications; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage*; D004359:Drug Therapy, Combination; D004415:Dyspepsia / Q000150:complications; D016481:Helicobacter Infections / Q000175:diagnosis; D016480:Helicobacter pylori; D006801:Humans; D010438:Peptic Ulcer Hemorrhage / Q000150:complications; D054328:Proton Pump Inhibitors; D018570:Risk Assessment
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors; D054328:Proton Pump Inhibitors; D001241:Aspirin